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Summary  Middle  East  Respiratory  Syndrome-coronavirus  (MERS-CoV)  was  reported
from  a  number  of  countries  in  the  Middle  East  and  Europe  with  a  reported  high  mor-
tality  rate.  MERS-CoV  was  initially  isolated  from  a  patient  from  Bisha,  Saudi  Arabia.Middle East Respiratory
Syndrome
A  recent  outbreak  of  MERS-CoV  infection  was  described  in  a  healthcare  facility.
Although,  the  recent  publications  on  this  topic  had  shed  light  on  the  epidemiology
of  the  disease,  many  questions  remain  to  be  answered.
©  2013  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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he  coronavirus  family  of  single-strand  RNA  viruses
s a  large  group  of  viruses  that  usually  cause  upper
espiratory  tract  infection  in  humans.  The  ﬁrst  two
embers,  229E  and  OC43,  were  recognized  in  the
960s [1].  It was  not  until  2003  when  this  family
f viruses  attracted  attention  due  to  the  discov-
ry of  a  new  virus  that  caused  the  pandemic  severe
cute respiratory  syndrome  (SARS)  [2,3].  Later  on,
wo additional  novel  coronaviruses,  NL63  and  HKU1,
ere identiﬁed  in  2004  and  2005  [4,5].  These  two
iruses cause  respiratory  tract  infections  and  they
re widely  spread  within  the  human  population  [4].
hus, thee  four  known  human  coronaviruses,  229E,
C43, NL63,  and  HKU1,  cause  mild  to  moderate
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ttp://dx.doi.org/10.1016/j.jiph.2013.06.001pper-respiratory  tract  illness  without  signiﬁcant
orbidity.
Since  September  2012,  a  novel  coronavirus  was
ound  to  cause  sporadic  cases  of  severe  acute  respi-
atory infection  (SARI).  The  virus  strain  was  not
nown previously  and  genome  sequencing  showed
hat this  new  virus  belongs  to  the  genus  Beta-
oronavirus and  is  distinct  from  other  known
oronaviruses and  from  SARS  [6]. In  a  small  num-
er of  patients  with  SARS,  7/28  (25%)  had  low
iters of  neutralizing  antibodies  for  this  newly
iscovered virus  [7].  The  newly  discovered  virus
as recently  named  the  Middle  East  Respiratory
yndrome-coronavirus  (MERS-CoV)  [8].
MERS-CoV was  initially  isolated  from  the  respi-
atory tract  of  a  patient  from  Bisha,  Saudi  Arabia.
he patient  developed  severe  pneumonia  and  acute
enal failure  in  June  2012  [6]. This  case  was  ﬁrst
ublished  in  ProMed  in  September  2012  [9]. The
isease apparently  runs  a severe  course  in  the
 Sciences. Published by Elsevier Ltd. All rights reserved.
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Table  1  Deﬁnition  of  close  contacts.
Setting  Deﬁnition
Airplane  setting  Aircraft  passengers  in  the
same  row  and  the  two
rows  in  front  and  behind  a
symptomatic  case.
Household  setting Prolonged  (>15  min)
face-to-face  contact  with
the  conﬁrmed  case  during
the  illness  in  a household
setting.
Household  setting
who  also  visited
the  patient  in
hospital
As above  and  hospital
visiting.
Healthcare  setting  (i)  Healthcare  worker
(HCW)  who  provided
direct  clinical  or  personal
care  to  or  examined  a
symptomatic  conﬁrmed
case  or  was  within  close
vicinity  of  an
aerosol-generating
procedure  AND  who  was
not  wearing  full  personal
protective  equipment
(PPE)  at  the  time;  or  (ii)  a
visitor  to  the  hospital  who
was  not  wearing  PPE  at
the  bedside  of  a  conﬁrmed
case;  full  PPE  was  deﬁned
as  correctly  ﬁtted  high
ﬁltration  mask  (FFP3),
gown,  gloves  and  eye
protection;
Other  setting  A  person  who  had
prolonged  (>15  min)
face-to-face  contact  with
a  conﬁrmed  symptomatic
case  in  any  other  enclosed
setting.
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majority  of  patients.  In  a  family  cluster  of  four
cases, a  spectrum  of  disease  severity  was  observed.
One  patient  had  atypical  presentation  of  fever,  uri-
nary retention,  ﬂank  pain,  diarrhea,  renal  colic,
and urinary  tract  infection.  Another  patient  had
severe  disease  and  death,  and  milder  illness  in  two
young family  members  [10].
From 6  April  to  May  17,  2013,  21  conﬁrmed  cases
of MERS-CoV  infection  were  reported  in  the  region
of Al-Ahsa  in  the  Eastern  Province  of  Saudi  Ara-
bia (16  males  and  5  females,  median  age  56  years)
with nine  deaths  [11,12]. The  majority  of  the  ini-
tial cases  were  associated  with  a  single  health  care
facility.  In  addition,  three  family  members  of  cases
and two  health  care  workers  who  had  contact  with
laboratory  conﬁrmed  cases  developed  the  infection
[11,12].  In  addition,  two  cases  were  reported  by
France.  The  ﬁrst  case  became  ill  after  a 9-day  vaca-
tion to  Dubai,  UAE.  The  second  case,  reported  on  12
May, is  a  patient  who  shared  a  room  at  a  health  care
facility  with  the  ﬁrst  case  [13].  In  Tunisia,  there
were two  laboratory  conﬁrmed  cases,  a brother
and a  sister,  who  are  thought  to  have  caught  the
virus from  their  father,  who  became  ill  three  days
after  returning  from  a  visit  to  Qatar  and  Saudi
Arabia and  died  on  10  May  [14]. Countries  with
reported cases  are  Saudi  Arabia,  Qatar,  Jordan,  and
the United  Arab  Emirates.  The  United  Kingdom,
Germany, France  and  Tunisia  also  reported  cases
among  people  who  had  been  to  the  Middle  East
or have  had  contact  with  travelers  returning  from
these areas.  Thus,  globally,  from  September  2012  to
end of  May  2013,  there  are  49  laboratory-conﬁrmed
cases  of  infection  with  MERS-CoV,  with  a  mortality
rate of  55%  [15].
The  exact  mode  of  transmission  of  the  virus  is
not known.  In  February  2013,  MERS-CoV  infection
was conﬁrmed  in  an  adult  male  in  the  United  King-
dom [16].  The  patient  developed  severe  respiratory
tract infection  10  days  after  traveling  to  Pakistan
and Saudi  Arabia.  A  contact  tracing  of  135  identiﬁed
two  secondary  cases  among  family  members  with-
out recent  travel:  one  developed  severe  respiratory
illness and  died,  the  other  had  an  inﬂuenza-like
illness. No  other  severe  cases  were  identiﬁed  nor
were MERS-CoV  detected  in  respiratory  samples
among 135  contacts  followed  for  10  days.
Who is considered  a  close  contact?  In  the  UK
study mentioned  above  [17]  a  close  contact  deﬁ-
nition is  shown  in  Table  1. From  that  study  it  was
concluded that  there  was  a  limited  human  to  human
transmission  [17].  Health  care  associated  transmis-
sion of  MERS-CoV  was  described  in  Jordan  in  April
2012. However,  the  ﬁrst  time  healthcare  workers
were involved  in  healthcare  transmission  of  MERS-
CoV was  diagnosed  after  exposure  to  patients  with
c
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nSource:  Adopted from Ref. [16].
ERS-CoV  in  May  15  2013.  The  Saudi  Ministry  of
ealth announced  two  cases  of  MERS-CoV  infection
n healthcare  workers  who  were  exposed  to  patients
ith conﬁrmed  infection  [18]. In  a recent  publica-
ion  from  Saudi  Arabia,  four  patients’  members  of
n extended  family  had  a  total  of  28  persons  living
n the  extended  household,  with  frequent  contact
nd more  often  between  husbands  and  wives  and
heir children.  None  of  the  family  members  apart
rom  the  four  patients  and  none  of  124  health
are workers  who  had  contact  with  the  patients
eveloped respiratory  symptoms  or  illness  [10].
he data  indicates  a  clear  evidence  of  limited,
on-sustained, human-to-human  transmission.  The
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xact  route  of  transmission  is  not  clear,  but  the
ost  likely  modes  of  transmission  include  droplet
nd contact  transmission.  But  further  studies  are
equired to  better  understand  the  risks.
When  caring  for  patients  with  suspected  or
onﬁrmed cases  of  MERS-CoV,  the  following  rec-
mmendations  for  infection  control  measures  in
ospital  settings  include:  standard  precautions,
roplet precautions  (wearing  a  medical  mask  when
n close  contact  (within  1 m)  and  upon  entering  the
oom or  cubicle  of  the  patient);  and  performing
and hygiene  in  accordance  with  the  World  Health
rganization’s  (WHO)  5  moments  of  hand  hygiene.
dditional  measures  include  wearing  a  particulate
espirator when  performing  aerosol-generating  pro-
edures in  addition  to  other  precautions  as  outlined
y WHO  document  [19].  A  recent  publication  of
ERS-CoV  outbreak  in  healthcare  setting,  there  was
vidence  of  person-to-person  transmission  and  the
utbreak was  aborted  by  the  implementation  of
asic infection  control  measures  [12].  The  center
or Disease  Control  and  prevention,  United  States,
ecommends  the  placement  of  the  patient  in  an
irborne  Infection  Isolation  Room  (AIIR)  [20].
As our  understanding  of  the  infection  evolves,
ome questions  remain  to  be  answered  and  include:
he exact  routes  of  transmission,  the  incubation
eriod, the  true  distribution  in  animals  and  humans,
nd how  best  to  manage  these  patients.  Does  the
irus cause  mild  and  unrecognized  disease  and  what
s reported  represents  only  the  tip  of  an  iceberg?  To
urther answer  this  question,  there  is a  need  for  a
obust and  deployable  speciﬁc  serological  test  to
nvestigate  mild  cases  and  asymptomatic  individ-
als.
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